These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8001379)

  • 1. Continuous infusions of haloperidol in critically ill patients.
    Crippen D; Ermakov S
    Crit Care Med; 1995 Jan; 23(1):214-5. PubMed ID: 8001379
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous infusion of haloperidol in agitated, critically ill patients.
    Stern TA
    Crit Care Med; 1994 Mar; 22(3):378-9. PubMed ID: 8124985
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous infusion of haloperidol controls agitation in critically ill patients.
    Riker RR; Fraser GL; Cox PM
    Crit Care Med; 1994 Mar; 22(3):433-40. PubMed ID: 8124994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe, refractory agitation with a haloperidol drip.
    Fernandez F; Holmes VF; Adams F; Kavanaugh JJ
    J Clin Psychiatry; 1988 Jun; 49(6):239-41. PubMed ID: 3379030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous haloperidol for tranquilization in critical care patients: a review and critique.
    Ziehm SR
    AACN Clin Issues Crit Care Nurs; 1991 Nov; 2(4):765-77. PubMed ID: 1954061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion of haloperidol.
    Dixon D; Craven J
    Am J Psychiatry; 1993 Apr; 150(4):673. PubMed ID: 8465890
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of haloperidol infusions to control delirium in critically ill adults.
    Seneff MG; Mathews RA
    Ann Pharmacother; 1995; 29(7-8):690-3. PubMed ID: 8520081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of haloperidol in the agitated, critically ill pediatric patient with burns.
    Brown RL; Henke A; Greenhalgh DG; Warden GD
    J Burn Care Rehabil; 1996; 17(1):34-8. PubMed ID: 8808357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of haloperidol and associated complications in the agitated, acutely ill pediatric burn patient.
    Ratcliff SL; Meyer WJ; Cuervo LJ; Villarreal C; Thomas CR; Herndon DN
    J Burn Care Rehabil; 2004; 25(6):472-8. PubMed ID: 15534454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of haloperidol in agitated critically ill children.
    Harrison AM; Lugo RA; Lee WE; Appachi E; Bourdakos D; Davis SJ; McHugh MJ; Weise KL
    Clin Pediatr (Phila); 2002; 41(1):51-4. PubMed ID: 11866368
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous haloperidol (Serenase) in treatment of severe psychomotor agitation].
    Skausig OB
    Ugeskr Laeger; 1979 Dec; 141(49):3371-2. PubMed ID: 524519
    [No Abstract]   [Full Text] [Related]  

  • 12. Agitation in the critically ill patient: a marker of health or a plea for treatment?
    Schweickert W; Hall JB
    Crit Care Med; 2005 Jan; 33(1):263-5. PubMed ID: 15644697
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study.
    Al-Qadheeb NS; Skrobik Y; Schumaker G; Pacheco MN; Roberts RJ; Ruthazer RR; Devlin JW
    Crit Care Med; 2016 Mar; 44(3):583-91. PubMed ID: 26540397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill.
    Metzger E; Friedman R
    J Clin Psychopharmacol; 1993 Apr; 13(2):128-32. PubMed ID: 8463445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Dose Ketamine in Chronic Critical Illness.
    Moitra VK; Patel MK; Darrah D; Moitra A; Wunsch H
    J Intensive Care Med; 2016 Mar; 31(3):216-20. PubMed ID: 26025196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of haloperidol prophylaxis in critically ill patients with a high risk of delirium: a systematic review.
    Santos E; Cardoso D; Neves H; Cunha M; Rodrigues M; Apóstolo J
    JBI Database System Rev Implement Rep; 2017 May; 15(5):1440-1472. PubMed ID: 28498176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose intravenous haloperidol in agitated cardiac patients.
    Weiden P; Shaw E; Bruun R; Mann JJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):375. PubMed ID: 3805333
    [No Abstract]   [Full Text] [Related]  

  • 18. Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for torsade de pointes: a comparative, case-based evaluation.
    Fongemie JM; Al-Qadheeb NS; Estes NA; Roberts RJ; Temtanakitpaisan Y; Ruthazer R; Devlin JW
    Pharmacotherapy; 2013 Jun; 33(6):589-97. PubMed ID: 23529904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients.
    Tesar GE; Murray GB; Cassem NH
    J Clin Psychopharmacol; 1985 Dec; 5(6):344-7. PubMed ID: 4067002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedation of the agitated, critically ill patient without an artificial airway.
    Durbin CG
    Crit Care Clin; 1995 Oct; 11(4):913-36. PubMed ID: 8535986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.